Biochemical and pharmacological effects of the fermentation-derived antitumor agent, (alphaS,5S) -alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125)
Neil, G.L.; Berger, A.E.; McPartland, R.P.; Grindey, G.B.; Bloch, A.
Cancer Research 39(3): 852-856
1979
ISSN/ISBN: 0008-5472 PMID: 427775 Document Number: 140711
Document emailed within 1 workday
Related Documents
Jayaram, H.N.; Ardalan, B.; Deas, M.; Johnson, R.K. 1985: Mechanism of resistance of a variant of P388 leukemia to L-(alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin) Cancer Research 45(1): 207-212Allen, L.; Meck, R.; Yunis, A. 1980: The inhibition of gamma-glutamyl transpeptidase from human pancreatic carcinoma cells by (alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125; NSC-163501) Research Communications in Chemical Pathology and Pharmacology 27(1): 175-182
Meck, R.A.; Clubb, K.J.; Allen, L.M.; Yunis, A.A. 1981: Inhibition of cell cycle progression of human pancreatic carcinoma cells in vitro by L-(alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, Acivicin (NSC 163501) Cancer Research 41(11 Part 1): 4547-4553
Tsurumi, K.; Kokuba, S.; Okada, K.; Yanagihara, M.; Fujimura, H. 1986: Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl]propionic acid. 4th communication: inhibitory effects on rat adjuvant arthritis Arzneimittel-Forschung 36(12): 1810-1817
Tsurumi, K.; Kyuki, K.; Niwa, M.; Mibu, H.; Fujimura, H. 1986: Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10-oxodibenzo[b,f]thiepin-2-yl)propionic acid. 2nd communication: inhibitory effects on acute inflammation and prostaglandin-related reactions Arzneimittel-Forschung 36(12): 1801-1805
Zabska, R.; Jakóbiec, T.; Dobek, R.; Wilimowski, M.; Barczyńska, J.; Kedzierska-Goździk, L.; Wojewódzki, W.; Rutkowska, M.; Duś, E.; Szelag, A. 1991: Synthesis and pharmacological properties of derivatives of alpha-amino-beta-(p-chlorobenzoyl)-propionic acid and alpha-amino-gamma-(p-chlorophenyl)-tetrahydrofuran-2-one Polish Journal of Pharmacology and Pharmacy 43(4): 271-280
Nakamura, H.; Yokoyama, Y.; Motoyoshi, S.; Ishii, K.; Imazu, C.; Seto, Y.; Kadokawa, T.; Shimizu, M. 1983: The pharmacological profile of 2-(8-methyl-10,11-dihydro-11-oxodibenz[b,f]oxepin-2-yl)propionic acid (AD-1590), a new non-steroidal anti-inflammatory agent with potent antipyretic activity Arzneimittel-Forschung 33(11): 1555-1569
Sugawara, T.; Yoshida, M.; Shimoda, K.; Takada, S.; Miyamoto, M.; Nomura, M.; Kato, M. 1996: One-month oral toxicity study of the new quinolone antibacterial agent (S)-10-[(S)-(8-amino-6-azaspiro[3,4]octan-6-yl)-9-fluoro-2,3-dihydro-3- methyl-7-oxo-7H-pyrido [1,2,3-de] [1,4] benzoxazine-6-carboxylic acid hemihydrate in rats and cynomolgus monkeys Arzneimittel-Forschung 46(7): 705-710
Takeda, M.; Takagi, T. 1980: Effects of a new bronchodilator, (alpha RS)-3-formamido-4-hydroxy-alpha-[[[(alpha RS)-p-methoxy-alpha-methylphenethyl] amino] methyl] benzyl alcohol fumarate dihydrate (BD 40A) on gastric acid secretion and gastrointestinal motility Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 76(3): 185-191
Lettieri, G.; Brancaccio, G.; Larizza, A. 1981: Synthesis and pharmacological activity of 4-((7-chloro-quinolyl)amino)acylamides Bollettino Chimico Farmaceutico 120(5): 308-310
Castles, T.R.; Loth, E.; Crawford, C.R.; Lee, C.C. 1970: The neuromuscular blocking properties of the antimalarial agent, bis((chloro-7"-quinolyl-4")amino-2'-propyl)-1,4-piperazine Journal of Pharmacology and Experimental Therapeutics 172(1): 44-51
Hibino, Y.; Kawarabayashi, Y.; Kuwahata, T.; Ueda, N.; Shinguu, H. 1991: Enhancement of 5-fluorouracil (5-FU) antitumor effect of amino acid solution (methionine deprived amino acid solution: AO-90) in 5-FU-resistant Yoshida sarcoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 18(6): 1055-1057
Przybylska, T.; Niewiedziol, B. 1988: Selected aspects of amino acid-protein metabolism in juvenile onset insulin-dependent diabetes mellitus. I. Serum alpha-amino nitrogen level and diurnal urinary excretion of alpha-amino nitrogen and total nitrogen Pediatria Polska 63(1): 20-27
Cosnier, D.; Duchene-Marullaz, P.; Grimal, J.; Rispat, G.; Streichenberger, G. 1975: Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (Tolonidine), a new antihypertensive agent. I. Action on blood pressure and heart rate Arzneimittel-Forschung 25(10): 1557-1561
Gemba, T.; Ninomiya, M.; Matsunaga, K.; Ueda, M. 1993: Effects of a novel calcium antagonist, S-(+)-methyl-4,7-dihydro-3-isobutyl-6- methyl-4-(3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate (S-312-d), on ischemic amino acid release and neuronal injury in stroke-prone spontaneously hypertensive rats Journal of Pharmacology and Experimental Therapeutics 265(1): 463-467
Page, C.M.; Inglis, M.S.; Wheatley, D.N. 1982: The intracellular acid-extractable (acid-soluble) amino acid pool in mammalian cells: 4 An hypothesis to explain the effects of preloading on the exchange of amino acids across the cell membrane Cytobios 34(134): 105-123
Cosnier, D.; Labrid, C.; Rispat, G.; Streichenberger, G. 1975: Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (tolonidine), a new antihypertensive agent. II. Action on cardiac contraction, circulatory parameters, autonomic receptors and diuresis Arzneimittel-Forschung 25(11): 1802-1806
Guo, H.Y.; Sun, L.Y.; Tang, Y.; Yan, G.H.; Zhang, Z.P. 1988: Studies on pyridonecarboxylic acids as antibacterial agents. VI. Synthesis and antibacterial activity of 7-chloro-6-fluoro-1-ethyt-1, 4-dihydro-4-oxopyrido(2,3-c)pyridazine-3-carboxylic acid and derivatives Yao Xue Xue Bao 23(8): 566-573
Bozeman, E.N.; Srivatsan, S.; Mohammadi, H.; Daniels, D.; Shashidharamurthy, R.; Selvaraj, P. 2012: Ukrain, a plant derived semi-synthetic compound, exerts antitumor effects against murine and human breast cancer and induce protective antitumor immunity in mice Experimental Oncology 34(4): 340-347
Kunoh, Y.; Iguchi, A.; Gotoh, M.; Nomura, T.; Shibata, M.; Sakamoto, N. 1986: Hypoglycemic activity of MTP-1403 (2-amino-7,8-dihydro-4-piperazinyl-6H-thiopyrano 3,2-d pyrimidine), a new hypoglycemic agent Archives Internationales de Pharmacodynamie et de Therapie 280(2): 302-313